Our achievements. Our accomplishments. Our impact.



  • Ethical, Legal and Social Issues

    SCN established and funded a world-leading arms-length research program to examine the key social, legal and ethical implications of stem cell research and, based upon this credible and research-based evidence, has provided critical policy recommendations to government that have impacted not only how research is conducted in Canada, but how Canadians will access potential therapies in the future.

    READ STORY

  • Clinical Trials

    When the Stem Cell Network was first funded, its leadership considered that catalyzing a single clinical trial during its 14-year mandate would have been a success. Instead, the Network’s research investments have led to 12 clinical trials on various diseases, with even more in the development pipeline.

    READ STORY

  • Patient Engagement

    The Stem Cell Network engaged world-leading researchers and ethicists to provide Canadians with credible and accessible information on the latest advancements in stem cell research.

    READ STORY

  • Career Development

    The multidisciplinary research and training program offered by the Stem Cell Network enriched and accelerated the careers of hundreds of young researchers, many of whom can now be found across industry, government and academia.

    READ STORY

  • Commercialization

    The Stem Cell Network’s catalysis of commercialization of stem cell research has led to 399 patent applications, 60 issued patents, 43 licenses granted, the growth or launch of 11 start-up biotechnology companies and the establishment of a new Centre for the Commercialization of Regenerative Medicine (CCRM) to develop a strong industry presence in several emerging technology areas likely to be crucial to the future delivery of stem cell-based therapies.

    READ STORY

  • Cancer Stem Cells

    A seminal Canadian discovery demonstrated that cancer stem cells are a significant reason for high relapse rates after cancer treatments. In recognition of this, the Stem Cell Network has invested heavily finding ways to target and attack them.

    READ STORY